Infectious pleural effusion status and treatment progress

Area of Science:

• Medical Microbiology
• Pulmonology
• Infectious Diseases

Background:

• Pleural cavity infections pose a significant threat to human health.
• Pathophysiology involves three stages: exudative, fibrinopurulent, and organizational.
• Distinguishing pleural from pulmonary infections necessitates analyzing pleural effusion characteristics.

Purpose of the Study:

• To highlight the importance of analyzing bacterial and biochemical characteristics of pleural effusion for effective treatment of pleural cavity infections.
• To review current treatment strategies, including antibiotics, drainage, and surgical interventions.
• To emphasize the need for future research into prognosis, early evaluation, and stratification of patients.

Main Methods:

• Review of pathophysiology and clinical characteristics of pleural cavity infections.
• Analysis of diagnostic importance of pleural effusion properties.
• Evaluation of current therapeutic approaches, including medical and surgical options.

Main Results:

• Effective treatment relies on identifying pathogenic bacteria and biochemical markers in pleural effusion.
• Antibiotic therapy and adequate drainage form the cornerstone of management.
• Fibrinolytic agents lack routine evidence, but plasminogen activator and deoxyribonuclease show potential.
• Surgical options like thoracoscopy and decortication are reserved for treatment failures.

Conclusions:

• Accurate diagnosis and tailored treatment based on pleural effusion analysis are crucial for managing pleural infections.
• While most prognoses are favorable, complications like parapneumonic effusion and empyema require vigilant management.
• Further research into clinical characteristics is essential for improving patient prognosis and enabling early risk stratification.